Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
131
Frequently Asked Questions
What is Market Cap of Enanta Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Enanta Pharmaceuticals Inc market cap is $177.01M.
What is the 52-week high for Enanta Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Enanta Pharmaceuticals Inc 52 week high is $13.37 as of September 15, 2025.
What is the 52-week low for Enanta Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Enanta Pharmaceuticals Inc 52 week low is $4.09 as of September 15, 2025.
What is Enanta Pharmaceuticals Inc stock price today?
Enanta Pharmaceuticals Inc stock price today is $7.46.
What was Enanta Pharmaceuticals Inc stock price yesterday?
Enanta Pharmaceuticals Inc stock price yesterday was $8.28.
What is the PE ratio of Enanta Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Enanta Pharmaceuticals Inc’s P/E ratio is -1.91.
What is the Price-to-Book ratio of Enanta Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Enanta Pharmaceuticals Inc P/B ratio is 2.2327.
What is the 50-day moving average of Enanta Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Enanta Pharmaceuticals Inc 50-day moving average is $7.85.
How many employess does Enanta Pharmaceuticals Inc has?